Arthropoda, see Cockroaches;

Dust mites

Asian Americans, asthma prevalence, 70

Aspergillus fungi, 74, 75, 109, 110-111

Assessment, see Diagnosis;

Exposure assessment;

Risk assessment;

Tests and testing methods

Asthma, 6-7, 34, 57, 132, 147

allergen evaluation and control, 16, 19-20, 97-98

and allergic bronchopulmonary aspergillosis, 74

and animals, 9, 25, 36, 37, 107

and Aspergillus fumigatus, 67

attributable fractions, 59, 62-63

and bacteria, 113

and birds, 105

and bronchitis, 59, 69, 79-80

and cat dander, 68, 69, 93, 100

and chemical allergens, 27, 117, 119, 121-122, 123

and children, 6, 59, 61, 64, 67, 68, 69, 70

and cockroaches, 9, 47, 69, 92

costs, 7, 22, 34-35, 61, 84

deaths, 6, 8, 34, 64, 65-67, 70

diagnosis of, 12, 15, 16, 18, 30, 57-58, 166, 167, 175, 178, 180

and dust mites, 9, 16, 36, 67, 68, 88, 93, 199-200

epidemiological studies, 58-59

and fungi, 9, 67, 68, 74, 111, 117

and grasses, 68

historical studies, 37

hospitalization, 8, 34, 61, 64-65, 66, 68, 69

and microbes, 114

and monkeys, 105

patient education and management, 15, 19-20, 178, 233-240, 242-244

prevalence, 6, 7, 22, 34, 55, 60-61, 62-67

and quality of life, 58

and smoking, 59

Asymptomatic atopy, 42

Atopic dermatitis, 73

Atopy, 3, 42, 56

and chronic obstructive pulmonary disease, 81

Attributable fractions, 59-60

asthma, 59, 62-63

Aureobasidium, 75, 77

Australasia, asthma deaths, 64

Avoidance measures, see Control measures

Azo-dyes, 121

B

Bacteria, 29, 112-114, 213

Bedding, 24, 98

and dust mites, 9, 10, 16, 95-96

feathers in, 105

Behavior modification, see Education, of patients

Benefits systems, disability assessment, 17-18

Biocides, 115, 218, 225

Birds, 24-26, 105-106

and hypersensitivity pneumonitis, 75, 105-106

B lymphocytes, 141-142

Body plethysmography, 12

Briançon, France, 50, 51

Britain

asthma, 64

and humidifier fever, 78

sinusitis, 78

Bronchial hyperreactivity, 30-31, 57, 67, 68, 184

testing of, 179-180

Bronchiolitis, 69

Bronchitis, 3, 79-81, 83

and asthma, 59, 69, 79-80

Bronchoalveolar lavage, 181

Bronchoprovocation testing, 17, 180-181, 183

Bronchopulmonary aspergillosis, see Allergic bronchopulmonary aspergillosis

Building-related illness (BRI), 81-83, 206-207

Buildings, see Building-related illness;

Engineering control;

HVAC

Front Matter (R1-R11)

Executive Summary (1-33)

1 Introduction (34-43)

2 Magnitude and Dimensions of Sensitization and Disease Caused by Indoor Allergens (44-85)

3 Agents, Sources, Source Controls, and Diseases (86-130)

4 Mechanisms of Immune Function (131-152)

5 Medical Testing Methods (153-184)

6 Assessing Exposure and Risk (185-205)

7 Engineering Control Strategies (206-232)

8 The Role of Education (233-245)

References (246-280)

Acronyms (281-283)

Glossary (284-292)

Committee and Staff Biographies (293-298)

Index (299-308)